Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is also the world leader in microbial control providing innovative, chemistry-based and related solutions to destroy or to selectively inhibit the growth of harmful microorganisms. Its activities encompass the areas of water treatment, personal care, health and hygiene, industrial preservation, materials protection, and wood treatment. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition and agro markets.
Basel, CH
Size (employees)
10,342 (est)+5%
Lonza was founded in 1897 and is headquartered in Basel, CH
Report incorrect company information

Lonza Office Locations

Lonza has an office in Basel
Basel, CH (HQ)
38 Münchensteinerstrasse
Show all (1)
Report incorrect company information

Lonza Financials and Metrics

Lonza Financials

Market capitalization (5-Oct-2017)

14.2 b

Closing share price (5-Oct-2017)

Lonza's current market capitalization is €14.2 b.
Show all financial metrics
Report incorrect company information